The Watch

Computer Systems, Inc. (CCSI), a leader in perinatal systems software, announces a reseller agreement with AlertWatch, a leading provider of real-time clinical decision support software. Under this reseller agreement, CCSI will distribute, within the United States, AlertWatch:OB’s FDA 510(k)-cleared Maternal Safety System.

The Maternal Safety System, used by clinicians to monitor women in labor and delivery areas, provides real-time alerts and analytics to improve care.

“Shockingly, every eight to ten hours in the U.S. a mother dies during childbirth. This rate is three times the  rate of other industrialized countries,” explained AlertWatch founder and University of Michigan anesthesiologist Dr. Kevin Tremper. “And for every death, there are 70 near misses. Data shows that many

of these could have been prevented with a timelier response. Before now, providers haven’t had a tool that  gives them the right information in time to intervene.”

 To date, AlertWatch:OB has been used to assist with more than 15,000 births. In one recent study, a cross-functional survey revealed that 83% of providers approved of the application. Another recent study showed that the AlertWatch MEWS system was better at identifying postpartum hemorrhage (PPH) than the standard Maternal Early Warning Criteria (MEWC)*. This monitoring system is the first solution to integrate several critical features:

• MEWS alerts with proprietary filtering to improve the detection of PPH, while also reducing nuisance alerts by 95%.
• Automated risk assessment for each patient using the ACOG hemorrhage risk guidelines.
• Unit and patient-level dashboards with at-a-glance views across the entire continuity-of-care.
• Condition and provider-specific escalation pathways for improved response time and collaboration.

“We are very excited to be working with AlertWatch. Their Maternal Safety System will be a much-needed addition to help elevate the perinatal standard of care that CCSI, with the OBIX Perinatal Data System, continues to strive for. With Maternal mortality emerging as a critical topic in every labor and delivery unit worldwide; this safety system is a positive step in reducing the incidence rate of post-partum hemorrhage, its leading cause,” said CCSI VP, Business Development Rick Daniells

About Clinical Computer Systems, Inc.

CCSI is an employee-owned, high technology company located in Hoffman Estates, Illinois. For more than 25 years, CCSI has been a leader in perinatal systems with innovative, customer-driven, computer-based perinatal system, and support services.  The company is dedicated to the development of the OBIX Perinatal Data System and works to incorporate changes in technology, regulations, and standards in the obstetrical department that support hospitals’ strategic initiatives. For more, visit www.obix.com.

About AlertWatch, Inc.

AlertWatch, Inc. is an Ann Arbor-based firm, founded in 2011, that develops and markets clinical decision support systems for hospitals. AlertWatch simplifies patient monitoring with intuitive products across a variety of care settings. A 2018 study of AlertWatch:OR, our intraoperative monitoring solution, showed a reduction in post-operative length of stay and a reduction in hospital charges of $3,603. For more, visit www.alertwatch.com.

Contact information: rick.daniells@obix.com or justin.adams@alertwatch.com

In this post, we are highlighting the growing issue of anesthesia staffing shortages. The issue is multifaceted, and involves graduation rates, retirement rates, and the changing work life balance desired by providers.

Click the link below to learn more.

Staffing Shortage Whitepaper

The Joint Commission, on August 21, 2019, published an R3 report (requirement, rationale, reference) on maternal safety.

JCHO Report on Maternal Safety

In this report, they urge various actions to improve the safety of maternal care during child birth. In particular, they recommend patients are screened for hemorrhage risk (something AlertWatch:OB automatically evaluates once a minute), and that there is a process for responding to hemorrhages (our software alerts for MEWS criteria with additional filtering for reduced alarm fatigue).

We are glad they are bringing attention to maternal safety, and look forward to being a part of the overall effort to solve this epidemic.

Press Contact Information:

Justin Adams

justin.adams@alertwatch.com

February 28, 2018, Ann Arbor, Michigan. AlertWatch, an Ann Arbor—based digital health firm, today announced a major strategic relationship with Qualcomm life. Through the relationship, Qualcomm Life made a seven figure financial investment in AlertWatch and obtained the exclusive, world-wide rights to market the AlertWatch:OR product.

AlertWatch supports anesthesia providers by displaying a high-level dashboard view of the patient and alerting for certain quality and safety issues in real time so the care of each patient can be improved. The software integrates, analyzes, and displays hundreds of data points in a single, intuitive display of the human body.

“AlertWatch and Qualcomm Life (QCL) are a natural fit. In addition to having their chips powering billions of devices worldwide, their Capsule & 2net platform are in over 2,000 hospitals across the world, helping to bring forward the next generation of intelligent healthcare solutions. By seamlessly integrating our solutions onto their platforms, we can bring real-time monitoring & alerting solutions to anesthesia providers worldwide,” said Justin Adams, CEO of AlertWatch.

AlertWatch has over 100 proprietary algorithms, automated calculations, and alerts that can help providers quickly assess clinical situations without having to pore through dozens of electronic medical record (EMR) screens and tabs. The system integrates with all major EMR systems, and, of course, all major QCL technologies.

“The timing couldn’t be better. We’re expected to grow our revenue 4x in 2018 compared to 2017, and we’re already hiring additional team members to help us grow while continuing to provide best-in-class support to our hospital customers. And we’re carefully expanding our platform into the labor & delivery unit, as well as the ICU, and other wired locations throughout the hospital. The team at QCL has provided invaluable guidance as we expand what we’ve started,” added Justin.

This strategic relationship comes on the heels of a 6-year study published in the February 2018 issue Journal Anesthesiology. “That study showed that patients, when operated on with AlertWatch:OR providing support, had improved intraoperative care measures. More importantly, AlertWatch monitored patients went home a day earlier when compared to those who were not monitored by the system. This was not only great for the patient, but the hospital also saw charges go down $3,603 per case for these higher risk patients,” said Dr. Kevin Tremper, Chair of Anesthesiology at the University of Michigan, and the founder of AlertWatch.

Dr. James Mault, Senior VP & Chief Medical Officer of QCL, and a graduate of the University of Michigan for both his undergraduate and medical degrees, made a dozen “homecoming” trips to Ann Arbor while doing due diligence on AlertWatch. “Some of my best memories are from my time in Ann Arbor. What Kevin and the AlertWatch team have done is incredible. They’ve commercialized the first patient-specific integrated monitoring solution for the perioperative continuum of care. We’ll be work diligently with them to expand their predictive analytics and installation footprint over the coming years.”

For more information and to see a demo of the AlertWatch platform, visit www.alertwatch.com.

About AlertWatch
AlertWatch, Inc. produces real-time patient monitoring software focused on improving quality and safety. Their first solution, AlertWatch:OR, received FDA clearance in 2014. AlertWatch:OR is focused on improving intraoperative care to help reduce postoperative complications. AlertWatch:OB, a solution for monitoring mothers in the labor & delivery ward, is focused on reducing maternal mortality. AlertWatch:OB is pending FDA clearance. For more information, visit www.alertwatch.com, or email info@alertwatch.com.

About Qualcomm
Qualcomm’s technologies powered the smartphone revolution and connected billions of people. We pioneered 3G and 4G – and now we are leading the way to 5G and a new era of intelligent, connected devices. Our products are revolutionizing industries, including automotive, computing, IoT, healthcare and data center, and are allowing millions of devices to connect with each other in ways never before imagined. Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, all of our engineering, research and development functions, and all of our products and services businesses, including, our QCT semiconductor business.

FOR IMMEDIATE RELEASE

September 30, 2015, Ann Arbor, Michigan – AlertWatch is proud to announce that the University of Vermont Medical Center has purchased AlertWatch for use in their operating rooms.

AlertWatch supports anesthesia providers by displaying a high-level dashboard view of the patient, and alerting for certain quality and safety issues. The software integrates, analyzes, and displays hundreds of data points in a single, intuitive display of the human body.

“We are thrilled that the University of Vermont has decided to make AlertWatch a permanent part of their perioperative workflow. One of the best ways to help patients recover after surgery is to focus on quality & safety during the surgery, and that’s where AlertWatch can help,” said Justin Adams, CEO of AlertWatch.

AlertWatch has over a hundred proprietary algorithms, automated calculations, and alerts that can help providers quickly assess clinical situations without having to pore through dozens of electronic medical record (EMR) screens and tabs. The system integrates with all major EMR systems. A recent publication of data in the July issue of Anesthesiology showed that anesthesiologists who used AlertWatch during surgeries were more likely to properly treat hyperglycemia, a condition that is tied to increased surgical site infections.

Improving patient outcomes and reducing the length of stay are paramount concerns in running a hospital, and correspond to national quality assurance guidelines set by the Joint Commission and the Centers for Medicare & Medicaid Services (CMS). Both patient outcomes and a reduced length of stay also affect the revenue picture positively for healthcare organizations.

“Anesthesiologists are at the center of efforts to improve the safety of perioperative care. AlertWatch helps move these efforts forward,” said AlertWatch CEO Justin Adams. “With value-based reimbursement a reality for most providers, we think forward-looking hospitals can leverage AlertWatch:OR in managing both quality and cost savings initiatives.”

For more information and to see a demo of the AlertWatch platform, visit www.alertwatch.com.

About AlertWatch, Inc.

AlertWatch, Inc. produces clinical decision support systems for hospitals. Founded in 2011, AlertWatch simplifies patient monitoring with a focus on quality & safety. For more information, visit www.alertwatch.com.

About the University of Vermont Medical Center

The University of Vermont Medical Center (formerly Fletcher Allen Health Care), is a 447 bed regional referral center providing advanced care to approximately 1 million residents in Vermont and northern New York.  Together with our partners at the University of Vermont College of Medicine and the College of Nursing and Health Sciences, we are Vermont’s academic medical center.  The University of Vermont Medical Center is a member of The University of Vermont Health Network, a four hospital system established to deliver high quality academic medicine to every community we serve. Our partners are: The University of Vermont Health Network – Central Vermont Medical Center; The University of Vermont Health Network – Champlain Valley Physicians Hospital; and The University of Vermont Health Network – Elizabethtown Community Hospital.

The University of Vermont Medical Center also serves as a community hospital for approximately 150,000 residents in Chittenden and Grand Isle counties. For more information visit www.UVMHealth.org/MedCenter or visit our Facebook, Twitter, YouTube, and blog sites at http://www.UVMHealth.org/MedCenterSocialMedia

FOR IMMEDIATE RELEASE–March 22, 2016, Ann Arbor, MI–AlertWatch gains FDA clearance to sell its new mobile application

AlertWatch recently received FDA clearance for a brand new version of its patient monitoring software. The new version has hundreds of new features, all now available on the iPhone and iPad.

“Even though anesthesiologists are always near or in the ORs they’re supervising, our new mobile application gives them additional flexibility to check their cases and get alerts on the go. ” said AlertWatch CEO Justin Adams. “This all increases the likelihood they’ll notice potential quality or safety issues.”

Ann Arbor-based AlertWatch was founded in 2012 by U-M professor and anesthesiologist Dr. Kevin Tremper, Chair of the Department of Anesthesiology.

For more information, visit https://www.alertwatch.com/.

To download the app, visit https://itunes.apple.com/us/app/alertwatch-or/id975325329?mt=8

The entire team at AlertWatch is proud that one of our co-founders, Dr. Jim Bagian, has been chosen as a leader in the field of patient safety.

http://www.beckershospitalreview.com/lists/50-experts-leading-the-field-of-patient-safety-2015.html

Last week, AlertWatch received a shot in the arm from the Michigan business community, who have been supportive of the firm since its founding in 2012.

On Thursday, we received a $25,000 award for being the “Best Medical Device” firm at the Accelerate Michigan Investment Competition. The judges had their work cut out for them, as the entrants went all the way from drone software to a novel horse inflammation therapy.

We also won a case of beer from Atwater Brewers in Grosse Pointe. It was a great night, and I met a lot of new folks from the investment and start-up community.

The following night, I attended MLive’s Deals of the Year competition. We were invited to attend with our “deal” being the FDA clearance our AlertWatch:OR product received in February. I was truthfully shocked that we won. Although FDA clearance is a big and necessary step, it is early in AlertWatch’s journey.

Regardless, what both events underscored is how essential the support of the community has been for AlertWatch to accomplish its early milestones. Our firm has received investment from SPARK, BRCC (an investment group in Kalamazoo), several local angel investors, and now these two awards. Without these, we simply wouldn’t have the runway we’ve needed to get regulatory approval and our first customer.

Thanks!

FOR IMMEDIATE RELEASE — September 17, 2014, Ann Arbor, Michigan — AlertWatch is proud to announce that it has been chosen as a semi-finalist in the 2014 Accelerate Michigan Innovation Competition. The annual event brings over 50 Michigan startups together to compete for a multitude of prizes.

“AlertWatch is thrilled to join all of these great companies in the Accelerate Michigan Innovation competition,” said AlertWatch CEO, Justin Adams. “We think it’s a great way for the State of Michigan to encourage the local startup community, and to support the creation of highly-skilled jobs in the region.”

Semi-finalists were announced last night at the Techonomy Detroit event. That event brought entrepreneurs, policy experts and thought leaders together to discuss some of the pressing issues around technology and its impact on large cities like Detroit.

The competition will be held on November 4-6 at the Westin Book Cadillac hotel in Detroit. The teams will compete in multiple verticals, with the winner of the $500,000 grand prize being announced at Orchestra Hall the night of November 6^th.

For more information about AlertWatch and its products, visit www.alertwatch.com. For more information on the competition, please visit www.acceleratemichigan.org.

About AlertWatch, Inc.

AlertWatch develops real-time patient monitoring dashboards to help hospitals improve clinical quality, provider workflow, and billing accuracy. The product does this by integrating hundreds of pieces of data onto a visual representation of each patient, clearly communicating problems in a way that existing medical record systems do not. AlertWatch has been shown to provide significant clinical and financial benefits to its users, and with strong IP, a strong founding team, and strong sales and product pipelines, we are poised to help shepherd hospitals into this new era of accountable care. For more information, including investment information, visit www.alertwatch.com.

About the Accelerate Michigan Innovation Competition

Accelerate Michigan Innovation is an international business competition designed to highlight Michigan as a robust and vibrant venue for innovation and business opportunity. The Accelerate Michigan Innovation Competition is led by the Business Accelerator Network for Southeast Michigan, the Business Leaders for Michigan, the University Research Corridor, and the New Economy Initiative. These groups have aligned their efforts to bolster and advance Michigan’s entrepreneurial ecosystem through a variety of collaborative initiatives. Premier competition sponsors are The Michigan Economic Development Corporation, Quicken Loans, DTE Energy Foundation, Masco Corporation Foundation, and NextEnergy.